2,4-Diaminopyridine delta-opioid receptor agonists and their associated hERG pharmacology

Bioorg Med Chem Lett. 2009 Mar 15;19(6):1702-6. doi: 10.1016/j.bmcl.2009.01.106. Epub 2009 Feb 5.

Abstract

A number of libraries were produced to explore the potential of 2,4-diaminopyridine lead 1. The resulting diaminopyridines proved to be potent and selective delta-opioid receptor agonists. Several rounds of lead optimisation using library chemistry identified compound 17 which went on to show efficacy in an electromyography model of neuropathic pain. The structure-activity relationship of the series against the hERG ion channel proved to be a key selectivity hurdle for the series.

MeSH terms

  • 4-Aminopyridine / analogs & derivatives*
  • 4-Aminopyridine / chemical synthesis
  • 4-Aminopyridine / pharmacology
  • Analgesics, Opioid / pharmacology
  • Animals
  • Cell Line
  • Chemistry, Pharmaceutical / methods*
  • Combinatorial Chemistry Techniques
  • Drug Design
  • ERG1 Potassium Channel
  • Electromyography / methods
  • Ether-A-Go-Go Potassium Channels / chemistry*
  • Ether-A-Go-Go Potassium Channels / metabolism
  • Humans
  • Models, Chemical
  • Rats
  • Receptors, Opioid, delta / agonists*
  • Receptors, Opioid, delta / chemistry
  • Structure-Activity Relationship

Substances

  • Analgesics, Opioid
  • ERG1 Potassium Channel
  • Ether-A-Go-Go Potassium Channels
  • KCNH2 protein, human
  • Receptors, Opioid, delta
  • 2,4-diaminopyridine
  • 4-Aminopyridine